Clinical Study Results
Research Sponsor: MedImmune LLC
Drug Studied: MEDI6012
Study Purpose: This study was done to learn how well
MEDI6012 worked in participants who
had a type of heart attack called a STEMI
Protocol Number: D5780C00007
Thank you!
Thank you to the participants who took part in the clinical study for the study drug MEDI6012.
All of the participants helped the researchers learn more about MEDI6012 to help people who
had a sudden heart attack caused by a blockage in the arteries that supply blood to the heart.
This type of heart attack is called an “ST elevation myocardial infarction”, also called a STEMI.
MedImmune, LLC, sponsored this study and believes it is important to share the results of the
study with you and the public. An independent non-profit organization called CISCRP helped
prepare this summary of the study results for you. We hope it helps you understand and feel
proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1